These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7425017)

  • 21. Reversible contraception for the woman over 35 years of age.
    Archer DF
    Curr Opin Obstet Gynecol; 1992 Dec; 4(6):891-6. PubMed ID: 1450355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tubo-ovarian abscess occurring 16 years after supracervical hysterectomy.
    Tohya T; Yoshimura T; Onoda C
    Infect Dis Obstet Gynecol; 2003; 11(3):167-9. PubMed ID: 15022878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of ovarian actinomycosis.
    Iwasaki M; Nishikawa A; Akutagawa N; Fujimoto T; Teramoto M; Kudo R
    Infect Dis Obstet Gynecol; 2003; 11(3):171-3. PubMed ID: 15022879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IUD and salpingitis: a prospective study of pathomorphological changes in the oviducts in IUD-users.
    Beerthuizen RJ; Van Wijck JA; Eskes TK; Vermeulen AH; Vooijs GP
    Eur J Obstet Gynecol Reprod Biol; 1982 Feb; 13(1):31-41. PubMed ID: 7060816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuboovarian abscess and the intrauterine device (Majzlin Spring).
    Duckman S; Suarez J; Tantakesem P
    Am J Obstet Gynecol; 1973 Apr; 115(8):1157-8. PubMed ID: 4691475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contraceptive practice in women with systemic lupus erythematosus.
    Julkunen HA; Kaaja R; Friman C
    Br J Rheumatol; 1993 Mar; 32(3):227-30. PubMed ID: 8448613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship of genital tract actinomycetes and the development of pelvic inflammatory disease.
    Burkman R; Schlesselman S; McCaffrey L; Gupta PK; Spence M
    Am J Obstet Gynecol; 1982 Jul; 143(5):585-9. PubMed ID: 7091230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuboovarian abscess caused by Candida in a woman with an intrauterine device.
    Hsu WC; Lee YH; Chang DY
    Gynecol Obstet Invest; 2007; 64(1):14-6. PubMed ID: 17192715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CUP: contraceptive users pamphlet.
    Adv Contracept Deliv Syst; 1986 Feb; 2(1):84-103. PubMed ID: 12267728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is intrauterine device a risk factor for failure of conservative management in patients with tubo-ovarian abscess? An observational retrospective study.
    Kapustian V; Namazov A; Yaakov O; Volodarsky M; Anteby EY; Gemer O
    Arch Gynecol Obstet; 2018 May; 297(5):1201-1204. PubMed ID: 29478102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The end of IUD marketing in the United States: what does it mean for American women?].
    Forrest JD
    Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fertility awareness affects method use.
    Barnett B
    Netw Res Triangle Park N C; 1996; 17(1):9. PubMed ID: 12320448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Abscessing salpingo-oophoritis caused by Actinomyces in a woman using an IUD].
    Milia S; D'Ovidio N; Firinu C
    Minerva Ginecol; 1983 Apr; 35(4):231-3. PubMed ID: 6888796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use-effectiveness of oral and intrauterine contraception.
    Tietze C; Lewitt S
    Fertil Steril; 1971 Aug; 22(8):508-13. PubMed ID: 5110233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
    Vessey MP; Lawless M; McPherson K; Yeates D
    Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current trends in the diagnosis and treatment of tuboovarian abscess.
    Landers DV; Sweet RL
    Am J Obstet Gynecol; 1985 Apr; 151(8):1098-110. PubMed ID: 3885746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Contraception and pelvic infection in women].
    Keith L; Berger GS; Brown ER
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):49-58. PubMed ID: 12341241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complications of use of intrauterine devices among HIV-1-infected women.
    Sinei SK; Morrison CS; Sekadde-Kigondu C; Allen M; Kokonya D
    Lancet; 1998 Apr; 351(9111):1238-41. PubMed ID: 9643743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrauterine contraceptive device use and pelvic inflammatory disease.
    Kaufman DW; Shapiro S; Rosenberg L; Monson RR; Miettinen OS; Stolley PD; Slone D
    Am J Obstet Gynecol; 1980 Jan; 136(2):159-62. PubMed ID: 7352496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.